' 
SCIENTIFIC SCORE
Most Likely Effective
Based on 15 Researches
7.5
USERS' SCORE
Excellent
Based on 2 Reviews
9.5
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Calories
10
Total Fat
1 g
1%
Saturated Fat
0 g
0%
Trans Fat
0 g
**
Polyunsaturated Fat
0.5 g
**
Monounsaturated Fat
0 g
**
Cholesterol
10 mg
3%
Omega-3 Fish Oil
1000 mg
**
EPA (Eicosapentaenoic Acid)
180 mg
**
DHA (Docosahexaenoic Acid)
120 mg
**
Top Medical Research Studies
9.5
Eicosapentaenoic acid helps migraines
A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.
Directly addresses EPA efficacy
We conducted a thorough investigation into how eicosapentaenoic acid (EPA) can impact episodic migraines. In a carefully designed study, we gathered 70 participants who experienced these migraines and divided them into two groups. One group received a high dose of EPA, while the other was given a placebo. This approach ensured that we could see the true effects of EPA without bias.
After 12 weeks, the results were compelling. We noticed that those taking EPA had significantly fewer migraine days compared to the placebo group. In fact, participants on EPA reported an average reduction of 4.4 days per month, while those on the placebo had barely any change. The EPA group also experienced less need for acute headache medication and marked improvements in headache severity, disability, anxiety, depression, and overall quality of life.
Perhaps most striking was how particularly beneficial EPA seemed to be for female participants. Overall, the study demonstrated that high-dose EPA not only helped reduce the frequency and severity of migraines but also positively influenced the psychological aspects of living with migraines.
This suggests that incorporating EPA into migraine management could be a valuable option for those suffering from episodic migraines, especially as there were no major adverse effects reported.
After 12 weeks, the results were compelling. We noticed that those taking EPA had significantly fewer migraine days compared to the placebo group. In fact, participants on EPA reported an average reduction of 4.4 days per month, while those on the placebo had barely any change. The EPA group also experienced less need for acute headache medication and marked improvements in headache severity, disability, anxiety, depression, and overall quality of life.
Perhaps most striking was how particularly beneficial EPA seemed to be for female participants. Overall, the study demonstrated that high-dose EPA not only helped reduce the frequency and severity of migraines but also positively influenced the psychological aspects of living with migraines.
This suggests that incorporating EPA into migraine management could be a valuable option for those suffering from episodic migraines, especially as there were no major adverse effects reported.
Read More
9.5
Omega-3s effectively reduce migraines
High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.
Directly addresses migraine treatment
We explored the potential of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as effective treatments for preventing migraines. In a comprehensive analysis of 40 randomized controlled trials involving over 6,600 participants, we compared high doses of these omega-3 fatty acids with other commonly prescribed migraine medications.
Our findings revealed that higher dosages of EPA/DHA resulted in significant decreases in both the frequency and severity of migraines compared to a placebo. Specifically, we observed a notable standardized mean difference in migraine frequency and severity, indicating these omega-3s might be a more effective option than current medications.
Moreover, the acceptance rates of this treatment were promising, suggesting that individuals found it easier to tolerate compared to traditional migraine drugs. This evidence supports the idea that high dosage EPA/DHA could be a leading choice for migraine prevention, potentially offering a safer and more effective alternative for many patients.
Our findings revealed that higher dosages of EPA/DHA resulted in significant decreases in both the frequency and severity of migraines compared to a placebo. Specifically, we observed a notable standardized mean difference in migraine frequency and severity, indicating these omega-3s might be a more effective option than current medications.
Moreover, the acceptance rates of this treatment were promising, suggesting that individuals found it easier to tolerate compared to traditional migraine drugs. This evidence supports the idea that high dosage EPA/DHA could be a leading choice for migraine prevention, potentially offering a safer and more effective alternative for many patients.
Read More
9
Eicosapentaenoic acid reduces migraines
The relationship between different fatty acids intake and frequency of migraine attacks.
Direct focus on EPA's effects
We investigated how the intake of eicosapentaenoic acid (EPA), a type of omega-3 fatty acid, might affect the frequency of migraine attacks. In a study involving 105 migraine patients aged 15 to 50, we examined their usual dietary habits through a food frequency questionnaire and tracked their migraine occurrences over a month.
Our findings revealed a notable trend: lower consumption of EPA was tied to an increased number of migraine attacks. Specifically, participants with reduced EPA intake experienced a higher frequency of migraines, with data indicating a significant statistical relationship. We also found that this connection held true for both men and women alike, emphasizing the potential importance of dietary choices in managing migraines.
Conversely, we did not observe any significant link between saturated fatty acids (SFA) and migraine frequency, suggesting that not all dietary fats impact migraines the same way. Overall, our results point to a promising association between omega-3 fatty acids, particularly EPA, and reduced migraine attacks, inviting further research to deepen our understanding of this relationship.
Our findings revealed a notable trend: lower consumption of EPA was tied to an increased number of migraine attacks. Specifically, participants with reduced EPA intake experienced a higher frequency of migraines, with data indicating a significant statistical relationship. We also found that this connection held true for both men and women alike, emphasizing the potential importance of dietary choices in managing migraines.
Conversely, we did not observe any significant link between saturated fatty acids (SFA) and migraine frequency, suggesting that not all dietary fats impact migraines the same way. Overall, our results point to a promising association between omega-3 fatty acids, particularly EPA, and reduced migraine attacks, inviting further research to deepen our understanding of this relationship.
Read More
Most Useful Reviews
9.5
Migraine relief
Taking these capsules regularly has normalised my sleep and significantly improved my migraines. When I feel symptoms starting, I take my pills, add extra magnesium, and my migraine typically subsides within hours, compared to previously being incapacitated for half a day. My PMS and menstruation have also become much more manageable with regular magnesium intake, and my chronic nasopharynx pain has lessened. I've also been taking omega-3 and other supplements, which may contribute. I've experienced no side effects; the quality is excellent and natural.
Read More
9.5
Migraine management
These capsules have normalised my sleep and improved my migraines significantly. When I feel the beginnings of a migraine, I take my usual pills and some extra magnesium, and the migraine usually eases within a few hours. In the past, I would be out of action for much longer. Additionally, my PMS and menstruation are much easier to handle with consistent magnesium intake, and I have experienced no side effects. Overall, the quality and natural ingredients are superb.
Read More
Most Recommended Products for Migraine
ChildLife Essentials Essentials
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 4 Reviews
9.5
Garden of Life Vitamin Code
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 1 Reviews
9.5
NOW Foods Potassium Citrate
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 3 Reviews
9.3
Medical Researches
SCIENTIFIC SCORE
Most Likely Effective
Based on 15 Researches
7.5
9.5
Eicosapentaenoic acid helps migraines
A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.
Directly addresses EPA efficacy
We conducted a thorough investigation into how eicosapentaenoic acid (EPA) can impact episodic migraines. In a carefully designed study, we gathered 70 participants who experienced these migraines and divided them into two groups. One group received a high dose of EPA, while the other was given a placebo. This approach ensured that we could see the true effects of EPA without bias.
After 12 weeks, the results were compelling. We noticed that those taking EPA had significantly fewer migraine days compared to the placebo group. In fact, participants on EPA reported an average reduction of 4.4 days per month, while those on the placebo had barely any change. The EPA group also experienced less need for acute headache medication and marked improvements in headache severity, disability, anxiety, depression, and overall quality of life.
Perhaps most striking was how particularly beneficial EPA seemed to be for female participants. Overall, the study demonstrated that high-dose EPA not only helped reduce the frequency and severity of migraines but also positively influenced the psychological aspects of living with migraines.
This suggests that incorporating EPA into migraine management could be a valuable option for those suffering from episodic migraines, especially as there were no major adverse effects reported.
After 12 weeks, the results were compelling. We noticed that those taking EPA had significantly fewer migraine days compared to the placebo group. In fact, participants on EPA reported an average reduction of 4.4 days per month, while those on the placebo had barely any change. The EPA group also experienced less need for acute headache medication and marked improvements in headache severity, disability, anxiety, depression, and overall quality of life.
Perhaps most striking was how particularly beneficial EPA seemed to be for female participants. Overall, the study demonstrated that high-dose EPA not only helped reduce the frequency and severity of migraines but also positively influenced the psychological aspects of living with migraines.
This suggests that incorporating EPA into migraine management could be a valuable option for those suffering from episodic migraines, especially as there were no major adverse effects reported.
Read More
9.5
Omega-3s effectively reduce migraines
High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.
Directly addresses migraine treatment
We explored the potential of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as effective treatments for preventing migraines. In a comprehensive analysis of 40 randomized controlled trials involving over 6,600 participants, we compared high doses of these omega-3 fatty acids with other commonly prescribed migraine medications.
Our findings revealed that higher dosages of EPA/DHA resulted in significant decreases in both the frequency and severity of migraines compared to a placebo. Specifically, we observed a notable standardized mean difference in migraine frequency and severity, indicating these omega-3s might be a more effective option than current medications.
Moreover, the acceptance rates of this treatment were promising, suggesting that individuals found it easier to tolerate compared to traditional migraine drugs. This evidence supports the idea that high dosage EPA/DHA could be a leading choice for migraine prevention, potentially offering a safer and more effective alternative for many patients.
Our findings revealed that higher dosages of EPA/DHA resulted in significant decreases in both the frequency and severity of migraines compared to a placebo. Specifically, we observed a notable standardized mean difference in migraine frequency and severity, indicating these omega-3s might be a more effective option than current medications.
Moreover, the acceptance rates of this treatment were promising, suggesting that individuals found it easier to tolerate compared to traditional migraine drugs. This evidence supports the idea that high dosage EPA/DHA could be a leading choice for migraine prevention, potentially offering a safer and more effective alternative for many patients.
Read More
9
Eicosapentaenoic acid reduces migraines
The relationship between different fatty acids intake and frequency of migraine attacks.
Direct focus on EPA's effects
We investigated how the intake of eicosapentaenoic acid (EPA), a type of omega-3 fatty acid, might affect the frequency of migraine attacks. In a study involving 105 migraine patients aged 15 to 50, we examined their usual dietary habits through a food frequency questionnaire and tracked their migraine occurrences over a month.
Our findings revealed a notable trend: lower consumption of EPA was tied to an increased number of migraine attacks. Specifically, participants with reduced EPA intake experienced a higher frequency of migraines, with data indicating a significant statistical relationship. We also found that this connection held true for both men and women alike, emphasizing the potential importance of dietary choices in managing migraines.
Conversely, we did not observe any significant link between saturated fatty acids (SFA) and migraine frequency, suggesting that not all dietary fats impact migraines the same way. Overall, our results point to a promising association between omega-3 fatty acids, particularly EPA, and reduced migraine attacks, inviting further research to deepen our understanding of this relationship.
Our findings revealed a notable trend: lower consumption of EPA was tied to an increased number of migraine attacks. Specifically, participants with reduced EPA intake experienced a higher frequency of migraines, with data indicating a significant statistical relationship. We also found that this connection held true for both men and women alike, emphasizing the potential importance of dietary choices in managing migraines.
Conversely, we did not observe any significant link between saturated fatty acids (SFA) and migraine frequency, suggesting that not all dietary fats impact migraines the same way. Overall, our results point to a promising association between omega-3 fatty acids, particularly EPA, and reduced migraine attacks, inviting further research to deepen our understanding of this relationship.
Read More
9
Dietary intervention reduces headache pain
Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial.
Study evaluates dietary impacts
We conducted a randomized trial to understand how modifying dietary omega-3 and omega-6 fatty acids influences chronic headache conditions, particularly migraines. Patients with daily headaches followed two different dietary plans: one that included a high level of omega-3 and a low level of omega-6, and another that just reduced omega-6 intake. Over 12 weeks, we gathered both clinical and biochemical data to evaluate the outcomes.
Interestingly, the results highlighted that the group consuming more omega-3 fatty acids had significant improvements in their headache symptoms. They reported fewer headache days per month and spent less time each day suffering from headaches compared to those who only lowered their omega-6 intake. Additionally, we noted notable changes at the biochemical level, indicating increased levels of certain markers related to pain relief in the higher omega-3 group.
Our findings suggest that enhancing omega-3 intake while reducing omega-6 can lead to better management of chronic headaches, altering pain-related lipid mediators and ultimately improving quality of life for those suffering from such conditions.
Interestingly, the results highlighted that the group consuming more omega-3 fatty acids had significant improvements in their headache symptoms. They reported fewer headache days per month and spent less time each day suffering from headaches compared to those who only lowered their omega-6 intake. Additionally, we noted notable changes at the biochemical level, indicating increased levels of certain markers related to pain relief in the higher omega-3 group.
Our findings suggest that enhancing omega-3 intake while reducing omega-6 can lead to better management of chronic headaches, altering pain-related lipid mediators and ultimately improving quality of life for those suffering from such conditions.
Read More
8
Eicosapentaenoic acid aids migraines
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial.
Highly relevant migraine treatment study
In a recent study aimed at understanding the role of eicosapentaenoic acid (EPA) in treating chronic migraines, we conducted a random, placebo-controlled trial with participants diagnosed with chronic migraines. The participants were split into two groups; one group received 1000 mg of EPA twice daily for eight weeks, while the other group took placebo softgels.
Our main focus was to evaluate whether daily EPA supplementation could reduce the frequency of migraine attacks and improve overall quality of life. We carefully tracked symptoms at four and eight weeks, relying on established measures like the Headache Impact Test-6 to quantify changes.
The results from this study were promising. We observed that taking 2000 mg of EPA daily showed potential benefits as a preventative treatment for chronic migraines. Participants reported a decrease in migraine headache days and lower severity levels, making it a valuable option to consider in managing chronic migraines effectively.
Our main focus was to evaluate whether daily EPA supplementation could reduce the frequency of migraine attacks and improve overall quality of life. We carefully tracked symptoms at four and eight weeks, relying on established measures like the Headache Impact Test-6 to quantify changes.
The results from this study were promising. We observed that taking 2000 mg of EPA daily showed potential benefits as a preventative treatment for chronic migraines. Participants reported a decrease in migraine headache days and lower severity levels, making it a valuable option to consider in managing chronic migraines effectively.
Read More
User Reviews
USERS' SCORE
Excellent
Based on 2 Reviews
9.5
9.5
Migraine relief
Taking these capsules regularly has normalised my sleep and significantly improved my migraines. When I feel symptoms starting, I take my pills, add extra magnesium, and my migraine typically subsides within hours, compared to previously being incapacitated for half a day. My PMS and menstruation have also become much more manageable with regular magnesium intake, and my chronic nasopharynx pain has lessened. I've also been taking omega-3 and other supplements, which may contribute. I've experienced no side effects; the quality is excellent and natural.
Read More
9.5
Migraine management
These capsules have normalised my sleep and improved my migraines significantly. When I feel the beginnings of a migraine, I take my usual pills and some extra magnesium, and the migraine usually eases within a few hours. In the past, I would be out of action for much longer. Additionally, my PMS and menstruation are much easier to handle with consistent magnesium intake, and I have experienced no side effects. Overall, the quality and natural ingredients are superb.
Read More
